Exclusivity Information
Paylean45 Paylean9 holds 1 exclusivity out of which 1 has expired. Details of Paylean45 Paylean9's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Apr 25, 2009 |
About Paylean45 Paylean9
Paylean45 Paylean9 is a drug
owned by ELANCO US INC.
Paylean45 Paylean9 uses
Ractopamine Hydrochloride as the active
ingredient.
Active Ingredient:
Paylean45 Paylean9 uses
Ractopamine Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Ractopamine Hydrochloride ingredient.